GLP1Meter
Home / Side effects

GLP-1 hair loss treatment

You are dealing with a symptom and want to know if it is expected.

Reference and calculator, not medical advice. This page explains how something works; it does not tell you what to take. Last reviewed August 2026.

Start with the finding that shapes everything else on this page: none of the seven prescribing information documents names a treatment for this. Not a supplement, not a topical, not a dose adjustment protocol. The reaction is documented; a remedy for it is not.

That is worth sitting with before buying anything, because the gap between "this reaction is real and in the labelling" and "this product treats it" is where most of the money in this category is made. The first is documented. The second has no support in the source material at all.

What each label actually reports

Incidence figures come from the adverse-reaction sections of the prescribing information. The two weight-management products report trial data; the diabetes products list alopecia only as a postmarketing report.

ProductReported inWomenMen
Wegovy SemaglutideClinical trials4%0.9%
Zepbound TirzepatideClinical trials7.1%0.5%
Ozempic SemaglutidePostmarketing reports onlyno denominatorno denominator
Mounjaro TirzepatidePostmarketing reports onlyno denominatorno denominator
Rybelsus Semaglutide (oral)Postmarketing reports onlyno denominatorno denominator
Saxenda LiraglutidePostmarketing reports onlyno denominatorno denominator
Trulicity DulaglutidePostmarketing reports onlyno denominatorno denominator

A postmarketing entry means the reaction has been reported after approval but the label gives no rate, because spontaneous reports have no denominator. It is not evidence that the rate is lower — only that it was not measured. Every figure above is checked against the label linked at the foot of this page.

What the labels do supply is context that changes how urgent this looks. In the Zepbound trials, not one person taking the drug stopped because of hair loss — the only discontinuation for that reason was someone on placebo. Whatever people experienced, it was not, in that trial population, severe enough to outweigh continuing.

Common questions

What can a clinician actually do here?
The genuinely useful thing is ruling out causes that have nothing to do with the medication. Thyroid dysfunction, iron deficiency and several common drugs all affect hair, are testable, and are treatable in ways this reaction is not. Attributing shedding to the GLP-1 without checking is how a treatable cause gets missed.
Do minoxidil or finasteride apply?
Those are treatments for androgenetic hair loss, which is a different pattern from what the trials recorded. Whether either is appropriate for you is a prescriber question and depends on what is actually happening to your hair — which requires someone looking at it.
Would slowing down my weight loss help?
The labels attribute the reaction to weight reduction and report higher rates at higher doses, so the question is reasonable. It is also not one to act on alone, because dose and rate of loss are the whole point of the treatment.
How long before I should escalate this?
The labels give no timeline, so there is no evidence-based threshold to quote. Sudden, patchy or accelerating loss is a different presentation from gradual diffuse thinning and warrants being seen rather than waited out.

Sources and last review

This page is general reference rather than a dosing table, so it quotes no figures from a label. Nothing here is reviewed by a clinician, and this site does not employ one — which is exactly why what I do publish stays traceable to its source.

Transcribed from the labels above and checked by me — Gavin, who builds this site, takes a GLP-1, and is not a clinician. Last reviewed August 2026. Found an error? [email protected] — I treat corrections as bugs. How this site is built and funded.

Also searched as: glp 1 hair loss treatment

Related